UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer

European journal of nuclear medicine and molecular imaging, 2018-03, Vol.45 (3), p.365-375

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Journal of clinical oncology, 2010-10, Vol.28 (29), p.4450-4456

2010

Link zum Volltext

Verfügbarkeit prüfen

Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma

Clinical cancer research, 2009-04, Vol.15 (8), p.2913-2919

2009

Link zum Volltext

Verfügbarkeit prüfen

Carcinoid tumor of the appendix: a consecutive series from 1237 appendectomies

World journal of gastroenterology : WJG, 2006-11, Vol.12 (41), p.6699

2006

Link zum Volltext

Verfügbarkeit prüfen

Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor

Archives of Endocrinology and Metabolism, 2017-09, Vol.61 (5), p.506-509

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-05, Vol.315 (17), p.1844

2016

Link zum Volltext

Verfügbarkeit prüfen

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

The lancet oncology, 2017-09, Vol.18 (9), p.1159-1171

2017

Link zum Volltext

Verfügbarkeit prüfen

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study

Annals of oncology, 2012-06, Vol.23 (6), p.1525-1530

2012

Link zum Volltext

Verfügbarkeit prüfen

(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

British journal of radiology, 2016-07, Vol.89 (1063), p.20160212-20160212

2016

Link zum Volltext

Verfügbarkeit prüfen

Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme

British journal of cancer, 2020-03, Vol.122 (7), p.1109-1117

2020

Link zum Volltext

Verfügbarkeit prüfen

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

British journal of cancer, 2009-05, Vol.100 (9), p.1444-1451

2009

Link zum Volltext

Verfügbarkeit prüfen

Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study

International journal of radiation oncology, biology, physics, 2003-07, Vol.56 (4), p.974-980

2003

Link zum Volltext

Verfügbarkeit prüfen

Correction: Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme

British journal of cancer, 2021-08, Vol.125 (5), p.773-773

2021

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

British journal of cancer, 2006-02, Vol.94 (4), p.481-485

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

Clinical colorectal cancer, 2018-12, Vol.17 (4), p.e617-e629

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

BMC cancer, 2014-12, Vol.14 (1), p.897-897, Article 897

2014

Link zum Volltext

Verfügbarkeit prüfen

Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma

Cancer, 2010-11, Vol.116 (22), p.5200-5206

2010

Link zum Volltext

Verfügbarkeit prüfen

OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages

Clinical proteomics, 2017-03, Vol.14 (1), p.9-9, Article 9

2017

Link zum Volltext

Verfügbarkeit prüfen

18 F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

British journal of radiology, 2016-07, Vol.89 (1063), p.20160212

2016

Link zum Volltext

Verfügbarkeit prüfen

18F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

British journal of radiology, 2016-05, Vol.89 (1063)

2016

Link zum Volltext

Verfügbarkeit prüfen

super(18) F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

British journal of radiology, 2016-01, Vol.89 (1063)

2016

Link zum Volltext

Verfügbarkeit prüfen

Familial adenomatous polyposis: clinical presentation, detection and surveillance

Acta gastro-enterologica belgica, 2011-09, Vol.74 (3), p.415-420

2011

Link zum Volltext

Verfügbarkeit prüfen

Human Equilibrative NucleosideTransporter 1 and Human Concentrative NucleosideTransporter 3 Predict Survival after Adjuvant GemcitabineTherapy in Resected Pancreatic Adenocarcinoma

Clinical cancer research, 2009, Vol.15 (8), p.2913-2919

2009

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian phase II study

International journal of radiation oncology, biology, physics, 2005-08, Vol.62 (5), p.1351-1356

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)
Webseiten
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Humans
(22)
Human Health Sciences
(20)
Sciences De La Santé Humaine
(20)
Oncology
(19)
Male
(17)
Aged
(16)
Female
(16)
Middle Aged
(16)
Adult
(14)
Tumors
(14)
Biological And Medical Sciences
(12)
Gastroenterology & Hepatology
(12)
Medical Sciences
(12)
Surgery
(12)
Gastroenterology. Liver. Pancreas. Abdomen
(11)
Gastroentérologie & Hépatologie
(11)
Aged, 80 And Over
(10)
Treatment Outcome
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma

Carcinoid tumor of the appendix: a consecutive series from 1237 appendectomies

Oncological patients' reactions to COVID‐19 pandemic: A single institution prospective study

Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study

(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study

Correction: Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma

OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages

18 F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

18F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

super(18) F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

Familial adenomatous polyposis: clinical presentation, detection and surveillance

Human Equilibrative NucleosideTransporter 1 and Human Concentrative NucleosideTransporter 3 Predict Survival after Adjuvant GemcitabineTherapy in Resected Pancreatic Adenocarcinoma

Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian phase II study

Suchergebnisse filtern